| CL1948A |
|
356559-13-2 |
SB-505124 HCl
SB-505124 hydrochloride
-
98+%
|
需詢價 |
C20H22ClN3O2 |
|
|
|
| CL1270A |
|
924898-09-9 |
LY2157299 monohydrate
Galunisertib monohydrate | LY2157299 monohydrate
-
98+%
|
需詢價 |
C22H19N5O.H2O |
|
|
|
| CL2608 |
|
123-78-4 |
D-神經(jīng)鞘氨醇 | D-鞘氨醇 | (2S,3R,4E)-2-氨基-4-十八碳烯-1,3-二醇
D-erythro-Sphingosine | (2S,3R,4E)-2-Amino-4-Octadecene-1,3-Diol | (E,2S,3R)-2-Aminooctadec-4-Ene-1,3-Diol | D-erythro-Sphingosine(DES)
3-5days
98+%
|
￥378.00 |
C18H37NO2 |
|
|
|
| CL2598 |
|
909910-43-6 |
A 83-01 | A-83-01
A 83-01 | A-83-01
-
98+%
|
需詢價 |
C25H19N5S |
|
|
|
| CL2440 |
|
133053-19-7 |
Go 6983
Go 6983
In-stock
98+%
|
￥600.00 |
C26H26N4O3 |
|
|
|
| HL1439 |
|
16837-52-8 |
氧化苦參堿丨苦參素
Oxymatrine
In-stock
98+%
|
￥600.00 |
C15H24N2O2 |
|
|
|
| CLA1323 |
|
1356922-05-8 |
比瑪盧單抗
Bimagrumab (Anti-ACVR2B)
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1157 |
|
705287-60-1 |
司他蘆單抗
Stamulumab (Synonyms: MYO-029)
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1151 |
|
272780-74-2 |
美替木單抗
Metelimumab
3-5days
95+%
|
￥3000.00 |
— |
|
|
|
| CLA1147 |
|
285985-06-0 |
樂德木單抗
Lerdelimumab
3-5days
95+%
|
￥9000.00 |
— |
|
|
|
| CLA1141 |
|
948564-73-6 |
非蘇木單抗
Fresolimumab
3-5days
95+%
|
￥6000.00 |
— |
|
|
|
| CL2227 |
|
1246304-91-5 |
Roy-Bz
Roy-Bz
3-5days
98+%
|
￥3200.00 |
C36H38O8 |
|
|
|
| CL2215 |
|
521984-48-5 |
SIS3 鹽酸鹽
SIS3 HCl
In-stock
98+%
|
￥1000.00 |
C28H28ClN3O3 |
|
|
|
| CL1934 |
|
497259-23-1 |
TPPB (α-Amyloid Precursor Protein Modulator)
TPPB (α-Amyloid Precursor Protein Modulator)
-
98+%
|
需詢價 |
C27H30F3N3O3 |
|
|
|
| CL1227 |
|
56124-62-0 |
戊柔比星
Valrubicin | AD-32
-
98+%
|
需詢價 |
C34H36F3NO13 |
|
|
|
| CL1270 |
|
700874-72-2 |
LY2157299
Galunisertib | LY2157299
3-5days
98+%
|
￥466.00 |
C22H19N5O |
|
|
|
| CL1082 |
|
301836-41-9 |
SB-431542
SB-431542
In-stock
98+%
|
￥350.00 |
C22H16N4O3 |
|
|
|
| CL1542 |
|
1062368-24-4 |
4-[6-(4-(哌嗪-1-基)苯基]吡唑并[1,5-a]嘧啶-3-基)喹啉
LDN-193189(DM3189)
In-stock
98+%
|
￥750.00 |
C25H22N6 |
|
|
|
| CL1057 |
|
1206711-16-1 |
DMH-1
DMH-1 (DMH1)
In-stock
98+%
|
￥400.00 |
C24H20N4O |
|
|
|
| CL1556 |
|
1432597-26-6 |
5-[6-[4-(1-哌嗪基)苯基]吡唑并[1,5-a]嘧啶-3-基]喹啉
LDN-212854 | BMP Inhibitor III | LDN 212854 | 5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
-
98+%
|
需詢價 |
C25H22N6 |
|
|
|
